Navigation Links
Cerimon Pharmaceuticals to Present at the 2007 BIO Investor Forum
Date:10/5/2007

SOUTH SAN FRANCISCO, Calif., Oct. 5 /PRNewswire/ -- Cerimon Pharmaceuticals, Inc., today announced Paul Sekhri, Cerimon's President and Chief Executive Officer, will present at the 2007 BIO Investor Forum on Thursday, October 11, 2007, at 9:30 a.m. PDT at the Palace Hotel in San Francisco. The presentation will take place in the Pacific Heights room.

About Cerimon Pharmaceuticals

Cerimon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutic products for autoimmune diseases, inflammation and pain. Cerimon believes these new treatment options will enable physicians specialized in treating these conditions to further improve the lives of their patients.

Cerimon currently has two drugs in development. Simulect(R) (basiliximab)entered a Phase IIb study for moderate-to-severe steroid-refractory ulcerative colitis in the first quarter of 2007, and the Company has initiated a Phase I study of a topical patch formulation of diclofenac sodium. This study will rapidly be followed by late-stage efficacy and safety studies in patients with acute musculoskeletal pain.

Cerimon is well financed, having closed a $70 million Series A financing in late 2005 with the premier investors MPM, Nomura Phase4 Ventures, and OrbiMed Advisors.

For more information on Cerimon, please visit the Company's website at http://www.cerimon.com/.


'/>"/>
SOURCE Cerimon Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):MSU research may lead to new ways to control honeybee parasite 277 percent of European pigs are castrated without anesthetic 2Tropical forests affected by habitat fragmentation store less biomass and carbon dioxide 2Tropical forests affected by habitat fragmentation store less biomass and carbon dioxide 3Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 1Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 2Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 3Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 4Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 5Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 6Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 7Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 8Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 9DAVISCO Foods International Inc and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose 6295 1DAVISCO Foods International Inc and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose 6295 2Childrens Hospitals and Clinics of Minnesota Teams With Geek Squad to Open First Ever In Hospital Precinct 6293 1Childrens Hospitals and Clinics of Minnesota Teams With Geek Squad to Open First Ever In Hospital Precinct 6293 2